|
|||||
|
|
A phase II study of the histone deacetylase inhibitor vorinostat combined with tamoxifen for the treatment of patients with hormone therapy-resistant breast cancer |
|
| Authors: | Munster P N Thurn K T Thomas S Raha P Lacevic M Miller A Melisko M Ismail-Khan R Rugo H Moasser M Minton S E |
| Affiliation: | Division of Hematology and Oncology, University of California, San Francisco, 1600 Divisadero, Rm A719 Box 1711, San Francisco, CA 94143, USA. pmunster@medicine.ucsf.edu |
| Abstract: | |
| Keywords: | histone deacetylase HDAC HDAC inhibitors breast cancer oestrogen receptor anti-oestrogen therapy |
| 本文献已被 PubMed 等数据库收录！ | |